$ AAPL

$ ABBV

$ ABNB

$ ACGL

$ ADI

$ ADM

$ ADP

$ ADSK

$ AEE

$ AEP

$ AES

$ AFL

$ AIG

$ AIZ

$ AJG

$ AKAM

$ ALB

$ ALGN

$ ALL

$ AMAT

$ AMCR

$ AMD

$ AME

$ AMGN

$ AMP

$ AMT

$ AMZN

$ ANET

$ AOS

$ APA

$ APD

$ APO

$ APTV

$ ARE

$ ATO

$ AVB

$ AWK

$ AXON

$ BA

$ BALL

$ BAX

$ BBY

$ BDX

$ BEN

$ BG

$ BIIB

$ BKNG

$ BLDR

$ BMY

$ BR

$ BRO

$ BXP

$ CAG

$ CAH

$ CARR

$ CAT

$ CBOE

$ CBRE

$ CCL

$ CDNS

$ CDW

$ CEG

$ CF

$ CHD

$ CHRW

$ CI

$ CINF

$ CL

$ CLX

$ CMCSA

$ CMG

$ CMI

$ CMS

$ COIN

$ COO

$ COP

$ COR

$ CPAY

$ CPT

$ CRL

$ CRWD

$ CSCO

$ CTRA

$ CTSH

$ CTVA

$ CVS

$ CVX

$ CZR

$ DAL

$ DASH

$ DAY

$ DD

$ DDOG

$ DE

$ DELL

$ DG

$ DGX

$ DIS

$ DOC

AMETEK posts a margin-driven EPS beat, raises guidance, and demonstrates strong operational execution despite modest revenue growth and macro risks.

# AMETEK Delivers Margin-Driven EPS Beat and Raises Guidance in Q2 FY2025

---

## Executive Summary

- **AMETEK (AME) delivered a strong Q2 FY2025, with adjusted EPS of $1.78 (+7% YoY) beating consensus, while revenue of $1.78B (+2.5% YoY) came in slightly below expectations.** The quarter’s outperformance was driven primarily by robust margin expansion and operational efficiencies, rather than top-line acceleration.
- **Margin quality was a standout,** with operating margins reaching 26.0% (up 20 bps YoY) and core margins expanding 90 bps YoY. The EMG segment led the way, posting a 210 bps YoY margin increase, reflecting successful cost management and integration of recent acquisitions.
- **Management struck a bullish tone,** highlighting record sales, strong free cash flow, and the effective neutralization of tariff headwinds. The company raised its full-year and Q3 EPS guidance, signaling confidence in continued operational execution and acquisition synergies.
- **Risks remain,** including macroeconomic and trade uncertainties, as well as project delays in China and headwinds in research/academia. However, AMETEK’s strong cash generation and balance sheet improvements provide a buffer and support ongoing M&A activity.
- **Catalyst watch:** The market is likely to react positively to the margin beat and raised guidance. Upcoming catalysts include further acquisition updates and progress on FARO Technologies’ margin targets.

---

## Performance Snapshot

| Metric         | Reported | Consensus | Surprise | YoY Change |
|----------------|----------|-----------|----------|------------|
| Revenue        | $1.78B   | ~$1.80B   | -$20M    | +2.5%      |
| Adjusted EPS   | $1.78    | $1.75     | +$0.03   | +7%        |
| Operating Margin | 26.0%  | —         | —        | +20 bps    |
| Core Margin    | —        | —         | —        | +90 bps    |
| EMG Segment Margin | —     | —         | —        | +210 bps   |
| Free Cash Flow Conversion | 115% of net income | — | — | — |

---

## Earnings Quality

AMETEK’s Q2 FY2025 results underscore **high earnings quality**, with margin expansion outpacing modest revenue growth. The company’s ability to drive profitability through operational efficiencies, pricing strategies, and successful acquisition integration (notably FARO Technologies) is evident. The strong margin performance, especially in the EMG segment, highlights disciplined cost control and synergy realization. The lack of detailed cost breakdown is offset by the clear improvement in both operating and core margins, suggesting effective management of COGS and SG&A.

---

## Management Commentary & Guidance

Management’s commentary was **decidedly bullish**, emphasizing record sales, margin expansion, and robust free cash flow. The company reported that tariff headwinds have been largely neutralized and highlighted operational flexibility. **Full-year adjusted EPS guidance was raised to $7.06–$7.20 (from $7.02–$7.18), with Q3 EPS guidance at $1.72–$1.76.** These updates reflect confidence in ongoing cost discipline, acquisition synergies, and a resilient demand environment.

---

## Key Risks

- **Macroeconomic and trade uncertainty** could impact demand and supply chain stability.
- **China project delays** and research/academia headwinds may weigh on near-term growth.
- **Integration risk** remains for recent acquisitions, though initial results are positive.
- **Cost inflation** is a potential headwind, though currently well-managed.

---

## Expected Market Reaction

Analyst and investor sentiment is expected to be **positive**, given the margin-driven EPS beat, raised guidance, and bullish management tone. The stock has already gained 14% over the past three months, and technical indicators (e.g., Golden Cross) suggest further upside potential. The market may begin to better appreciate AMETEK’s underlying margin strength and operational execution.

---

## Final Takeaway

**AMETEK’s Q2 FY2025 was a strong quarter, marked by high-quality earnings and robust margin expansion.** While revenue growth was modest, the company’s operational discipline, successful acquisition integration, and strong cash generation are underappreciated by the market. Risks remain, particularly from macro and China-specific factors, but the company’s balance sheet and free cash flow provide resilience.

**Upcoming catalysts:**  
- Progress updates on FARO Technologies’ margin targets and further M&A activity  
- Q3 results and any revisions to full-year guidance

AMETEK remains well-positioned for continued value creation, with the market likely underestimating the sustainability of its margin and cash flow improvements.

AMETEK (AME): Margin Strength Drives Guidance Raise

AMETEK’s margin gains and strong order flow are offset by rising tariff risks and inventory build, creating near-term uncertainty for revenue and cash flow.

# AMETEK, Inc.: Margin Resilience Meets Tariff Uncertainty—A Forward-Looking Earnings Outlook

## Executive Summary

We maintain a **Neutral** outlook on **AMETEK, Inc. (AME)** for the upcoming quarter, balancing robust margin expansion and order flow against rising tariff-related risks. **Q1 2025 results showed operating margin expansion to 26.3% and an 8.1% YoY increase in orders**, supporting near-term revenue stability. However, management’s explicit caution regarding **potential $70 million shipment delays to China** introduces material downside risk to quarterly revenue. The market may be underestimating the impact of **working capital build-up and inventory increases** on short-term cash flow and EPS, especially if supply chain disruptions persist.

## Recent Trends Signal What’s Next

AMETEK’s recent financial performance highlights a company executing well on cost and integration, but facing top-line headwinds:

- **Total revenue** in Q1 2025 was **$1.73B**, flat YoY, with organic sales down ~1% but offset by acquisitions.
- **Gross margin** improved to **36.1%** (up 80 bps YoY), and **operating margin** expanded to **26.3%** (up 230 bps YoY).
- **EPS** for Q1 was **$1.52**, up from $1.44 in Q1 2024.
- **Net margin** also improved, reflecting disciplined cost control.

### Quarterly Financial Trend Table

| Quarter      | Revenue ($B) | Gross Margin | Operating Margin | Net Margin | EPS   |
|--------------|--------------|--------------|------------------|------------|-------|
| Q2 2024      | 1.72         | 35.2%        | 25.1%            | 18.7%      | 1.41  |
| Q3 2024      | 1.74         | 35.6%        | 25.7%            | 19.1%      | 1.46  |
| Q4 2024      | 1.73         | 35.8%        | 26.0%            | 19.3%      | 1.48  |
| Q1 2025      | 1.73         | 36.1%        | 26.3%            | 19.7%      | 1.52  |

**Trend:** Margins and EPS have steadily improved, while revenue has plateaued, suggesting further upside depends on execution and external demand factors.

## Management’s Forward Tone and Positioning

Management’s Q1 2025 commentary was notably more cautious than in prior quarters, despite reiterating confidence in full-year performance:

- **“We’re confident in our robust operational excellence, but remain cautious on Q2 given ongoing tariff uncertainties.”** (Q1 2025 Earnings Call)
- The absence of specific Q2 guidance—unlike prior quarters—signals heightened uncertainty: **“We are not providing detailed Q2 guidance at this time due to potential shipment delays and evolving tariff impacts.”**
- Management emphasized **“pricing actions and localization”** as mitigation strategies, a shift from the prior focus on organic growth and acquisition synergies.

**Implication:** The tone has shifted from proactive growth to risk management, with a clear focus on navigating external headwinds.

## KPI Trends & Upcoming Quarter Drivers

Three KPIs will be critical for the next quarter:

- **Book-to-Bill Ratio:** **1.04** in Q1 2025 (vs. 1.01 in Q4 2024), indicating continued order strength.
- **Backlog:** **$3.47B** (up from $3.32B YoY), supporting revenue visibility.
- **Inventory:** **$1.07B** (up from $1.02B QoQ), suggesting precautionary builds.

### KPI Movement Table

| KPI             | Q1 2024 | Q4 2024 | Q1 2025 | YoY Change | QoQ Change |
|-----------------|---------|---------|---------|------------|------------|
| Book-to-Bill    | 1.00    | 1.01    | 1.04    | +0.04      | +0.03      |
| Backlog ($B)    | 3.22    | 3.32    | 3.47    | +0.25      | +0.15      |
| Inventory ($B)  | 0.98    | 1.02    | 1.07    | +0.09      | +0.05      |

**Impact:** Strong order flow and backlog support revenue, but rising inventory and working capital could pressure cash flow and margins if demand softens or shipments are delayed.

## Missed by the Street

- **Working Capital and Inventory Build:** The **$42.2M increase in working capital** and inventory build are subtle signals of management hedging against supply chain risk. This may **temporarily depress free cash flow and EPS** if shipment delays materialize.
- **Tariff Exposure Footnote:** A footnote in the 10-Q highlights **“potential for up to $70M in delayed shipments to China”**—a risk not fully reflected in consensus estimates.

## Scenarios for the Upcoming Quarter

### Scenario Table

| Scenario | Revenue ($B) | GAAP EPS | Operating Margin | Key Assumptions                                      |
|----------|--------------|----------|------------------|------------------------------------------------------|
| Bull     | 1.75         | 1.60     | 26.8%            | Tariff issues resolved, strong order conversion       |
| Base     | 1.73         | 1.52     | 26.3%            | Moderate tariff impact, some shipment delays          |
| Bear     | 1.70         | 1.45     | 25.5%            | Prolonged tariff disruptions, significant delays      |

**Most Likely:** The **Base case** is most probable, given management’s caution and current backlog/order trends. Tariff and shipment risks are real but appear manageable unless macro conditions deteriorate further.

## Appendix – Data Tables & Management Quotes

### Quarterly Financials Table

| Quarter      | Revenue ($B) | EPS   | Operating Margin |
|--------------|--------------|-------|------------------|
| Q2 2024      | 1.72         | 1.41  | 25.1%            |
| Q3 2024      | 1.74         | 1.46  | 25.7%            |
| Q4 2024      | 1.73         | 1.48  | 26.0%            |
| Q1 2025      | 1.73         | 1.52  | 26.3%            |

### KPI Movement Table

| KPI             | Q1 2024 | Q4 2024 | Q1 2025 | YoY Change | QoQ Change |
|-----------------|---------|---------|---------|------------|------------|
| Book-to-Bill    | 1.00    | 1.01    | 1.04    | +0.04      | +0.03      |
| Backlog ($B)    | 3.22    | 3.32    | 3.47    | +0.25      | +0.15      |
| Inventory ($B)  | 0.98    | 1.02    | 1.07    | +0.09      | +0.05      |

### Key Management Quotes

1. **“We’re confident in our robust operational excellence, but remain cautious on Q2 given ongoing tariff uncertainties.”**  
   *Q1 2025 Earnings Call* — Signals management’s dual focus on execution and risk.

2. **“We are not providing detailed Q2 guidance at this time due to potential shipment delays and evolving tariff impacts.”**  
   *Q1 2025 Earnings Call* — Unusual lack of guidance highlights uncertainty.

3. **“Pricing actions and localization are being deployed to offset near-term cost pressures.”**  
   *Q1 2025 Earnings Call* — Indicates proactive margin protection.

4. **“Our backlog remains at record levels, supporting revenue visibility into the second half.”**  
   *Q1 2025 Earnings Call* — Underpins confidence in medium-term outlook.

5. **“We have increased inventory levels to ensure supply continuity amid global disruptions.”**  
   *Q1 2025 10-Q* — Suggests risk management, but also potential cash flow drag.

6. **“Potential for up to $70 million in delayed shipments to China due to tariffs.”**  
   *Q1 2025 10-Q Footnote* — Quantifies a key risk for the upcoming quarter.

7. **“Integration of Paragon Medical is ahead of schedule, driving margin expansion in EMG.”**  
   *Q1 2025 Earnings Call* — Positive for segment profitability.

---

**Bottom Line:**  
AMETEK’s margin strength and order book provide a solid foundation, but near-term results will hinge on the company’s ability to navigate tariff headwinds and shipment timing. Investors should closely monitor working capital trends and management’s next update for clarity on risk mitigation and demand normalization.

AMETEK (AME): Margin Strength vs. Tariff Risks